BlackRock Health Sciences Trust (NYSE:BME) Sees Significant Growth in Short Interest

BlackRock Health Sciences Trust (NYSE:BME) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totaling 30,636 shares, an increase of 146.0% from the November 30th total of 12,455 shares. Based on an average daily volume of 37,256 shares, the days-to-cover ratio is currently 0.8 days. Based on an average daily volume of 37,256 shares, the days-to-cover ratio is currently 0.8 days.

BlackRock Health Sciences Trust Trading Up 0.0%

Shares of BlackRock Health Sciences Trust stock traded up $0.00 during trading on Friday, hitting $41.41. The stock had a trading volume of 28,659 shares, compared to its average volume of 48,323. The business has a fifty day moving average of $39.94 and a two-hundred day moving average of $37.70. BlackRock Health Sciences Trust has a fifty-two week low of $34.18 and a fifty-two week high of $41.72.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Wednesday, December 31st. Investors of record on Monday, December 22nd will be paid a $0.2621 dividend. The ex-dividend date of this dividend is Monday, December 22nd. This represents a c) dividend on an annualized basis and a yield of 7.6%.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its position in BlackRock Health Sciences Trust by 22.2% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after acquiring an additional 257 shares during the period. Comerica Bank increased its stake in shares of BlackRock Health Sciences Trust by 7.9% during the 1st quarter. Comerica Bank now owns 4,807 shares of the company’s stock worth $186,000 after purchasing an additional 353 shares during the last quarter. Oppenheimer & Co. Inc. increased its position in BlackRock Health Sciences Trust by 5.9% during the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock worth $250,000 after buying an additional 373 shares during the last quarter. SOA Wealth Advisors LLC. raised its holdings in BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock valued at $103,000 after buying an additional 469 shares in the last quarter. Finally, Royal Bank of Canada boosted its stake in shares of BlackRock Health Sciences Trust by 0.5% during the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after acquiring an additional 684 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.